Beth AnnLesnikoskiMDFACS
General Surgery • Jacksonville, FLBreast
Director, The Breast Program at Baptist MD Anderson
Dr. Lesnikoski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 Palm Avenue
3B-256
Jacksonville, FL 32207Phone+1 844-632-2278
Summary
- Dr. Beth Ann Lesnikoski is a General Surgeon based in Jacksonville, FL, with a subspecialty in breast surgery. She completed an internship and residency at Beth Israel Deaconess Medical Center, as well as a residency at Swedish Medical Center/First Hill. Lesnikoski is a graduate of the Class of 1987 at the Lewis Katz School of Medicine at Temple University. From 2017 to 2020, she served as the Founding Director at Baptist MD Anderson Cancer Center. She is recognized for her numerous scholarly publications on breast cancer and surgical education, with significant citations by other medical research works.
Education & Training
Beth Israel Deaconess Medical CenterResidency, Surgery, 1989 - 1992
Swedish Medical Center/First HillResidency, Surgery, 1988 - 1989- Beth Israel Deaconess Medical CenterInternship, Surgery, 1987 - 1988
Lewis Katz School of Medicine at Temple UniversityClass of 1987
Certifications & Licensure
FL State Medical License 2009 - 2025
MA State Medical License 1993 - 2011- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 43 citationsAddition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysisJennifer A. Crozier, Todd A. Pezzi, Caitlin Hodge, Slavica Janeva, Beth-Ann Lesnikoski
The Lancet. Oncology. 2020-12-01 - 12 citationsClinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.E Shelley Hwang, Peter Beitsch, Peter Blumencranz, David Carr, Anees Chagpar
JAMA Surgery. 2022-07-01 - 5 citationsAge-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee
Annals of Surgical Oncology. 2022-04-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
